Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.00    -2.00 (-1.28%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £880.53m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Pre-close trading update

17 Dec 2015 07:00

ELEMENTIS PLC - Pre-close trading update

ELEMENTIS PLC - Pre-close trading update

PR Newswire

London, December 16

17 December 2015

Elementis plc – pre-close trading updateElementis plc (ELM.L, the "Company" or the "Group"), the Global Specialty Chemicals Company, today issues a trading update ahead of its results for the full year endingΒ 31 December 2015, which will be announced on 1 March 2016.Since we issued our Interim Management Statement on 30 October 2015, markets have continued to be challenging and earnings per share for the current year is now projected to be at the lower end of the range of market expectations. Due to the cash generative nature of the Group and our ongoing focus on cash management, it is still anticipated that the Group’s year end net cash balance will be higher than the prior year balance of $64.2 million.Looking towards 2016, management expects Specialty Products to make progress against the current year, based on its strong and diverse market positions, new product launches and resilient contribution margins.In Chromium, the business will continue to benefit from its North American business model, where our unique delivery systems provide a value added service to customers. Export sales from North America, however, are likely to remain under pressure due to the strong US dollar. In addition, operating profit in the current year has benefited from approximately $5 million of β€œone-time” items, relating to a legal settlement and property easements which will not be repeated in 2016. Consequently, operating profit in 2016 in our Chromium operations is expected to be lower than the current year.Strong cash flow generation will continue to be an important feature of the Group’s performance in 2016 and both businesses will benefit next year from the recently announced measured actions to reduce our cost base.ENDSEnquiries:

Elementis+ 44 (0) 207 067 2999
David Dutro, Chief ExecutiveBrian Taylorson, Finance Director
FTI Consulting
+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.